ANIP logo

ANI Pharmaceuticals (ANIP) Total Expenses

Annual Total Expenses

$437.29 M
+$95.17 M+27.82%

31 December 2023

ANIP Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$168.03 M
+$35.51 M+26.80%

30 September 2024

ANIP Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIP Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.8%+44.3%
3 y3 years+95.2%+202.1%
5 y5 years+163.1%+281.8%

ANIP Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+95.2%at high+202.1%
5 y5 yearsat high+163.1%at high+281.8%
alltimeall timeat high>+9999.0%at high>+9999.0%

ANI Pharmaceuticals Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$168.03 M(+26.8%)
June 2024
-
$132.51 M(+8.3%)
Mar 2024
-
$122.38 M(-0.5%)
Dec 2023
$437.29 M(+27.8%)
$122.94 M(+5.6%)
Sept 2023
-
$116.44 M(+12.9%)
June 2023
-
$103.11 M(+8.8%)
Mar 2023
-
$94.80 M(+6.3%)
Dec 2022
$342.12 M(+40.0%)
$89.22 M(+5.2%)
Sept 2022
-
$84.80 M(-0.4%)
June 2022
-
$85.18 M(+2.7%)
Mar 2022
-
$82.92 M(+1.8%)
Dec 2021
$244.31 M(+9.0%)
$81.43 M(+46.4%)
Sept 2021
-
$55.62 M(-0.3%)
June 2021
-
$55.78 M(+8.4%)
Mar 2021
-
$51.48 M(-8.9%)
Dec 2020
$224.04 M(+17.8%)
$56.48 M(+12.6%)
Sept 2020
-
$50.18 M(-16.1%)
June 2020
-
$59.78 M(+3.8%)
Mar 2020
-
$57.62 M(+9.6%)
Dec 2019
$190.12 M(+14.4%)
$52.56 M(+19.4%)
Sept 2019
-
$44.01 M(-2.3%)
June 2019
-
$45.06 M(-7.1%)
Mar 2019
-
$48.48 M(+6.1%)
Dec 2018
$166.22 M(+12.6%)
$45.68 M(+12.5%)
Sept 2018
-
$40.59 M(+1.5%)
June 2018
-
$40.01 M(+0.1%)
Mar 2018
-
$39.95 M(+2.4%)
Dec 2017
$147.61 M(+44.9%)
$39.00 M(+0.4%)
Sept 2017
-
$38.83 M(+2.8%)
June 2017
-
$37.77 M(+18.0%)
Mar 2017
-
$32.00 M(+5.9%)
Dec 2016
$101.86 M(+133.5%)
$30.22 M(-1.2%)
Sept 2016
-
$30.60 M(+17.1%)
June 2016
-
$26.14 M(+75.6%)
Mar 2016
-
$14.89 M(+26.5%)
Dec 2015
$43.62 M(+21.3%)
$11.77 M(+2.1%)
Sept 2015
-
$11.52 M(+3.8%)
June 2015
-
$11.10 M(+20.3%)
Mar 2015
-
$9.23 M(-10.1%)
Dec 2014
$35.96 M(+23.2%)
$10.27 M(+11.7%)
Sept 2014
-
$9.19 M(+0.9%)
June 2014
-
$9.11 M(+23.0%)
Mar 2014
-
$7.40 M(+4.7%)
Dec 2013
$29.18 M(+14.6%)
$7.07 M(+0.7%)
Sept 2013
-
$7.03 M(-29.2%)
June 2013
-
$9.93 M(+221.5%)
Mar 2013
-
$3.09 M(-44.9%)
Dec 2012
$25.47 M(-50.4%)
$5.60 M(+2.9%)
Sept 2012
-
$5.45 M(-26.2%)
June 2012
-
$7.38 M(+4.7%)
Mar 2012
-
$7.05 M(-17.2%)
DateAnnualQuarterly
Dec 2011
$51.36 M(+11.5%)
$8.51 M(-35.6%)
Sept 2011
-
$13.21 M(+0.5%)
June 2011
-
$13.15 M(-20.3%)
Mar 2011
-
$16.50 M(+24.0%)
Dec 2010
$46.08 M(+16.1%)
$13.31 M(+17.9%)
Sept 2010
-
$11.29 M(+10.3%)
June 2010
-
$10.24 M(-8.9%)
Mar 2010
-
$11.24 M(-56.6%)
Dec 2009
$39.68 M(+82.1%)
$25.91 M(+427.6%)
Sept 2009
-
$4.91 M(+3.7%)
June 2009
-
$4.74 M(+14.7%)
Mar 2009
-
$4.13 M(-24.5%)
Dec 2008
$21.79 M(+137.6%)
$5.47 M(-19.3%)
Sept 2008
-
$6.77 M(+22.3%)
June 2008
-
$5.54 M(+38.0%)
Mar 2008
-
$4.01 M(+71.4%)
Dec 2007
$9.17 M(-16.6%)
$2.34 M(+6.9%)
Sept 2007
-
$2.19 M(-18.9%)
June 2007
-
$2.70 M(+39.2%)
Mar 2007
-
$1.94 M(-52.8%)
Dec 2006
$11.00 M(+15.0%)
$4.11 M(+307.9%)
Sept 2006
-
$1.01 M(-59.2%)
June 2006
-
$2.47 M(-27.5%)
Mar 2006
-
$3.41 M(+80.4%)
Dec 2005
$9.56 M(-22.6%)
$1.89 M(-7.6%)
Sept 2005
-
$2.04 M(-25.1%)
June 2005
-
$2.73 M(-5.8%)
Mar 2005
-
$2.90 M(-32.1%)
Dec 2004
$12.34 M(+102.0%)
$4.26 M(+43.8%)
Sept 2004
-
$2.96 M(+12.5%)
June 2004
-
$2.63 M(+6.2%)
Mar 2004
-
$2.48 M(+46.7%)
Dec 2003
$6.11 M(-8.0%)
$1.69 M(+15.4%)
Sept 2003
-
$1.46 M(-10.0%)
June 2003
-
$1.63 M(+22.5%)
Mar 2003
-
$1.33 M(-41.0%)
Dec 2002
$6.64 M(+46.6%)
$2.25 M(+27.7%)
Sept 2002
-
$1.76 M(+17.4%)
June 2002
-
$1.50 M(+36.2%)
Mar 2002
-
$1.10 M(-23.4%)
Dec 2001
$4.53 M(+23.7%)
$1.44 M(-1.4%)
Sept 2001
-
$1.46 M(+60.6%)
June 2001
-
$909.80 K(+26.0%)
Mar 2001
-
$722.00 K(-25.7%)
Dec 2000
$3.66 M(+128.4%)
$972.10 K(+42.8%)
Sept 2000
-
$680.90 K(-54.5%)
June 2000
-
$1.50 M(+189.8%)
Mar 2000
-
$516.20 K(+58.2%)
Dec 1999
$1.60 M(-42.3%)
-
June 1999
-
$326.20 K
Dec 1998
$2.78 M
-

FAQ

  • What is ANI Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual total expenses year-on-year change?
  • What is ANI Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly total expenses year-on-year change?

What is ANI Pharmaceuticals annual total expenses?

The current annual total expenses of ANIP is $437.29 M

What is the all time high annual total expenses for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual total expenses is $437.29 M

What is ANI Pharmaceuticals annual total expenses year-on-year change?

Over the past year, ANIP annual total expenses has changed by +$95.17 M (+27.82%)

What is ANI Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of ANIP is $168.03 M

What is the all time high quarterly total expenses for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly total expenses is $168.03 M

What is ANI Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, ANIP quarterly total expenses has changed by +$51.59 M (+44.31%)